510(k) K232027

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument by Sebia — Product Code GKA

K232027 is an FDA 510(k) premarket notification submitted by Sebia for the device "CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument". The FDA issued a decision of Substantially Equivalent on April 4, 2024. The device falls under product code GKA (Abnormal Hemoglobin Quantitation), a Class II device regulated under 21 CFR 864.7415. Sebia has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 4, 2024
Date Received
July 7, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Abnormal Hemoglobin Quantitation
Device Class
Class II
Regulation Number
864.7415
Review Panel
HE
Submission Type